Resumo
Definición
Anamnesis y examen
Principales factores de diagnóstico
- presença de fatores de risco
- dor abdominal
- alteração dos hábitos intestinais associados à dor
- inchaço ou distensão abdominal
- exame do abdome normal
Otros factores de diagnóstico
- passagem de muco nas fezes
- urgência de defecção
Factores de riesgo
- abuso físico e sexual
- transtorno do estresse pós-traumático (TEPT)
- idade <50 anos
- sexo feminino
- infecção entérica prévia
- história familiar
- estresse familiar e no trabalho
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- Hemograma completo
Pruebas diagnósticas que deben considerarse
- exame de sangue oculto nas fezes
- teste imunoquímico fecal (FIT) quantitativo
- testes sorológicos para doença celíaca
- calprotectina fecal
- lactoferrina fecal
- proteína C-reativa sérica
- velocidade de hemossedimentação (VHS)
- fator de crescimento de fibroblastos 19 sérico
- Teste de taurina-ácido homocólico marcado com selênio (SeHCAT)
- Coleta de fezes de 48 horas para ácidos biliares totais
- ensaio empírico do ligante de ácidos biliares
- teste do hidrogênio/metano no ar expirado
- exames de fezes para Giardia lamblia
- radiografia abdominal simples
- colonoscopia
- sigmoidoscopia flexível
Algoritmo de tratamiento
com constipação predominante
predominância de diarreia
alternação entre constipação e diarreia
Colaboradores
Autores
Ned Snyder, MD, MACP, AGAF
Professor of Medicine
Baylor College of Medicine and Marion DeBakey VA Hospital
Houston
TX
Adjunct Professor of Medicine
University of Texas Medical Branch
Galveston
TX
Disclosures
NS declares that he is a member on the board of the Kelsey Research Foundation, a non-profit organization. Kelsey Research Foundation has received and awarded private grants for the study of the microbiome in several diseases, including irritable bowel syndrome.
Peer reviewers
Douglas Drossman, MD
Professor of Medicine and Psychiatry
School of Medicine
Co-Director
UNC Center for Functional GI and Motility Disorders
Chapel Hill
NC
Disclosures
DD declares that he has no competing interests.
Simon McLaughlin, MBBS
Research Fellow
Department of Gastroenterology
St Mark's Hospital
Northwick Park
Harrow
UK
Disclosures
SM declares that he has no competing interests.
Horace Williams, MBBS
Clinical Research Fellow
Division of Medicine
Imperial College
London
UK
Disclosures
HW declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006 Apr;130(5):1480-91.Full text Abstract
Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016 May;150(6):1393-407. Abstract
Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021 Jan 1;116(1):17-44.Full text Abstract
Smalley W, Falck-Ytter C, Carrasco-Labra A, et al. AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D). Gastroenterology. 2019 Sep;157(3):851-4.Full text Abstract
Chey WD, Hashash JG, Manning L, et al. AGA clinical practice update on the role of diet in irritable bowel syndrome: expert review. Gastroenterology. 2022 May;162(6):1737-45.e5.Full text Abstract
Dionne J, Ford AC, Yuan Y, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol. 2018 Sep;113(9):1290-300. Abstract
Chang L, Sultan S, Lembo A, et al. AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation. Gastroenterology. 2022 Jul;163(1):118-36.Full text Abstract
Lembo A, Sultan S, Chang L, et al. AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea. Gastroenterology. 2022 Jul;163(1):137-51.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Doença de Crohn
- Colite ulcerativa
- Colite microscópica
More DifferentialsGuidelines
- Probiotics and prebiotics
- Irritable bowel syndrome in adults: diagnosis and management
More GuidelinesPatient information
Síndrome do intestino irritável: perguntas a fazer ao seu médico
Síndrome do intestino irritável: quais tratamentos funcionam?
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer